AbbVie (NYSE: ABBV) recently announced new results from two ongoing clinical trials evaluating epcoritamab, a CD3xCD20 bispecific T-cell-engaging antibody administered subcutaneously, in adult ...
The naming of nominee or vehicle companies is insufficient. For a trust, the trustee (s), settlor and beneficiaries must be named. (c) Name of offeror/offeree in relation to whose relevant securities ...
Tracsis plc (LON:TRCS – Get Free Report) insider Tracy Sheedy purchased 950 shares of the business’s stock in a transaction dated Tuesday, December 17th. The shares were purchased at an average price ...